BioSpace News Archive

Montmorency tart cherries have long enjoyed a reputation for reducing inflammation -- including studies showing benefits for easing pain from arthritis and gout, and soothing sore muscles after exercise.

Heritage Provider Network (HPN), one of the nation’s leading physician-led managed care organizations, announces that nominations are open for the fourth annual Heritage Healthcare Innovation Awards.

Adding another level of complexity, Sidney copes with post-traumatic stress disorder stemming from his deployment during Operation Enduring Freedom.

Ferring acquired exclusive U.S. commercialization rights for generic Ganirelix Acetate Injection for the prevention of premature ovulation in women undergoing fertility treatment

Nearly Six in Ten Recognize Access to Health Vitals is Important in an Emergency, Yet Nearly 30 Percent Keep Lab Results in a File Cabinet at Home Challenges Retaining and Accessing Key Medical Information are Key Drivers to This Lack of Knowledge

Mutations of the SCN2A gene are known to cause several neurological disorders including epilepsy, autism and a number of other neuro-related conditions, affecting tens of thousands of people worldwide.

New Bio-Integrative Orthopedic Fixation Material Provides Unprecedented Combination of Mechanical Strength and Natural Bone Healing in a Non-Permanent Implant

Bio-Thera intends to file for regulatory approval with the China National Medical Products Administration, the European Medicines Agency and the United States Food and Drug Administration in 2020.

Bristol-Myers Squibb Company (NYSE: BMY) today announced that the European Commission has approved the combination of Opdivo (nivolumab) 3 mg/kg plus Yervoy (ipilimumab) 1 mg/kg (“low-dose”) for the first-line treatment of patients with intermediate- and poor-risk advanced renal cell carcinoma (RCC).

Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX:NVCN) announced today that it has received written notification (the “Notification Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Rules for continued listing on the Nasdaq Capital Market.